The product may contain defective blisters with incorrect tablet arrangements and/or an empty blister pocket
Clik here to view.
of ConsumerAffairsImage may be NSFW.
Clik here to view.
Apotex Corp., of Weston, Fla., is recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP, which are used by women to prevent pregnancy.
The four recalled lots may contain defective blisters with incorrect tablet arrangements and/or an empty blister pocket.
No case of pregnancy or adverse event has been reported to Apotex.
The following products, which were shipped to wholesalers and distributors nationwide, are being recalled:
| NDC number on outer carton | NDC Number on inner carton | LotNumber | Expiration Date | Strength | Configuration/Count |
|---|---|---|---|---|---|
| 60505-4183-3 | 60505-4183-1 | 7DY008A | 8/2020 | 3MG / 0.03MG | Outer Carton: Contains three inner Cartons Inner Carton: Contains 1 blister with 21 active yellow color tablets and 7 placebo white color tablets. |
| 7DY009A | |||||
| 7DY010A | |||||
| 7DY011A |
What to do
Individuals should not interrupt their therapy, use a non-hormonal method of birth control, contact their health care provider for medical advice and may return the recalled packages to their pharmacist.
Consumers with questions regarding this recall may contact Apotex at (800) 706-5575 from8:30am 5:00pm, (EST) Monday thru Friday, or by email at Uscustomerservice@Apotex.com.
